Preparation of 16β-Estradiol Derivative Libraries as Bisubstrate Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 Using the Multidetachable Sulfamate Linker

被引:9
|
作者
Berube, Marie
Delagoutte, Florian
Poirier, Donald [1 ]
机构
[1] CHU Laval, Res Ctr, CHUQ, Med Chem Lab, Quebec City, PQ G1V 4G2, Canada
来源
MOLECULES | 2010年 / 15卷 / 03期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Solid-phase synthesis; sulfamate linker; steroid; inhibitor; 17; beta-HSD; ESTRADIOL-ADENOSINE HYBRIDS; CHEMICAL-SYNTHESIS; BIOLOGICAL EVALUATION; POTENT INHIBITORS; ESTRONE; DESIGN; BREAST; CANCER; DEHYDROGENASE; STEROIDS;
D O I
10.3390/molecules15031590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Combinatorial chemistry is a powerful tool used to rapidly generate a large number of potentially biologically active compounds. In our goal to develop bisubstrate inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1) that interact with both the substrate (estrone or estradiol) and the cofactor (NAD(P) H) binding sites, we used parallel solid-phase synthesis to prepare three libraries of 16 beta-estradiol derivatives with two or three levels of molecular diversity. From estrone, we first synthesized a sulfamate precursor that we loaded on trityl chloride resin using the efficient multidetachable sulfamate linker strategy recently developed in our laboratory. We then introduced molecular diversity [one or two amino acid(s) followed by a carboxylic acid] on steroid nucleus by Fmoc peptide chemistry. Finally, after a nucleophilic cleavage, libraries of 30, 63 and 25 estradiol derivatives were provided. A library of 30 sulfamoylated estradiol derivatives was also generated by acidic cleavage and its members were screened for inhibition of steroid sulfatase. Biological evaluation on homogenated HEK-293 cells overexpressing 17 beta-HSD1 of the estradiol derivatives carrying different oligoamide-type chains at C-16 first revealed that three levels of molecular diversity (a spacer of two amino acids) were necessary to interact with the adenosine part of the cofactor binding site. Second, the best inhibition was obtained when hydrophobic residues (phenylalanine) were used as building blocks.
引用
收藏
页码:1590 / 1631
页数:42
相关论文
共 50 条
  • [21] Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Brozic, Petra
    Kocbek, Petra
    Sova, Matej
    Kristl, Julijana
    Martens, Stefan
    Adamski, Jerzy
    Gobec, Stanislav
    Rizner, Tea Lanisnik
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 229 - 234
  • [22] Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activity
    Maltais, Rene
    Trottier, Alexandre
    Barbeau, Xavier
    Laguee, Patrick
    Perreault, Martin
    Theriault, Jean-Francois
    Lin, Sheng-Xiang
    Poirier, Donald
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 161 : 24 - 35
  • [23] Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
    Spadaro, Alessandro
    Negri, Matthias
    Marchais-Oberwinkler, Sandrine
    Bey, Emmanuel
    Frotscher, Martin
    PLOS ONE, 2012, 7 (01):
  • [24] Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis
    Poutanen, M
    Isomaa, V
    Peltoketo, H
    Vihko, R
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (5-6): : 525 - 532
  • [25] Estradiol and estrone C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase:: Blocking of ER+ breast cancer cell proliferation induced by estrone
    Laplante, Yannick
    Cadot, Christine
    Fournier, Michelle-Audrey
    Poirier, Donald
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (04) : 1849 - 1860
  • [26] Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitro
    Berenyi, Agnes
    Frotscher, Martin
    Marchais-Oberwinkler, Sandrine
    Hartmann, Rolf W.
    Minorics, Renata
    Ocsovszki, Imre
    Falkay, George
    Zupko, Istvan
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (04) : 695 - 703
  • [27] Design, chemical synthesis, and in vitro biological evaluation of simplified estradiol-adenosine hybrids as inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Berube, Marie
    Poirier, Donald
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 2009, 87 (08): : 1180 - 1199
  • [28] Estradiol-adenosine hybrid compounds designed to inhibit type 1 17-β-hydroxysteroid dehydrogenase
    Poirier, D
    Boivin, RP
    Tremblay, MR
    Bérubé, M
    Qiu, W
    Lin, SX
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (26) : 8134 - 8147
  • [29] Retinoic acids promote the action of aromatase and 17β-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17β-estradiol in placental cells
    Zhu, SJ
    Li, Y
    Li, H
    Wang, YL
    Xiao, ZJ
    Vihko, P
    Piao, YS
    JOURNAL OF ENDOCRINOLOGY, 2002, 172 (01) : 31 - 43
  • [30] 17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production
    Aka, Juliette A.
    Mazumdar, Mausumi
    Chen, Chang-Qing
    Poirier, Donald
    Lin, Sheng-Xiang
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (04) : 832 - 845